Ditchcarbon
  • Contact
  1. Organizations
  2. Vectura
Public Profile
Pharmaceutical Preparation Manufacturing
GB
updated 13 days ago

Vectura

Company website

Vectura Group plc, headquartered in Great Britain, is a leading player in the pharmaceutical industry, specialising in the development of inhalation products and drug delivery solutions. Founded in 1997, Vectura has achieved significant milestones, including partnerships with major pharmaceutical companies to enhance respiratory therapies. The company focuses on innovative formulations and device technologies, particularly for asthma and chronic obstructive pulmonary disease (COPD). Vectura's unique approach combines expertise in inhalation science with advanced manufacturing capabilities, positioning it as a trusted partner in the respiratory market. With a strong presence in Europe and North America, Vectura has established itself as a key contributor to improving patient outcomes through its core products and services. Its commitment to research and development continues to drive its success and market leadership in the inhalation therapeutics sector.

DitchCarbon Score

How does Vectura's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

27

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Vectura's score of 27 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.

47%

Let us know if this data was useful to you

Vectura's reported carbon emissions

In 2023, Vectura reported total carbon emissions of approximately 14,578,000 kg CO2e, with about 13,983,000 kg CO2e classified under Scope 3 emissions, and approximately 595,000 kg CO2e from Scope 1 and 2 combined. This marks a slight increase from 2022, when total emissions were about 14,385,000 kg CO2e, with Scope 3 emissions at approximately 13,981,000 kg CO2e and Scope 1 and 2 emissions at around 404,000 kg CO2e. Vectura's emissions data is cascaded from its parent company, Vectura Group plc, reflecting a corporate family relationship. The company has not set specific reduction targets or initiatives as part of the Science Based Targets initiative (SBTi) or other climate pledges. The absence of defined reduction strategies highlights the need for Vectura to enhance its climate commitments in line with industry standards, particularly given the significant proportion of emissions attributed to Scope 3, which often encompasses indirect emissions from the supply chain and product use.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20142017201820222023
Scope 1
142,000
0,000,000
0,000,000
-
-
Scope 2
1,272,000
0,000,000
0,000,000
-
-
Scope 3
-
-
-
00,000,000
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Vectura's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Vectura is in GB, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Vectura is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Indivior

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated about 5 hours ago

BioDelivery Sciences International, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Teva Pharmaceuticals

IL
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251028.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy